Berman David's most recent trade in Immunocore Holdings plc - ADR was a trade of 31,341 Ordinary Shares done at an average price of $17.5 . Disclosure was reported to the exchange on Dec. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 04 Dec 2025 | 31,341 | 31,341 | - | 17.5 | 547,214 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 31,341 | 12,404 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.26 per share. | 04 Dec 2025 | 31,341 | 0 | - | 40.3 | 1,261,789 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2025 | 572 | 11,832 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 04 Dec 2025 | 572 | 0 | - | 40.1 | 22,960 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 04 Dec 2025 | 572 | 572 | - | 17.5 | 9,987 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Nov 2025 | 69,404 | 69,404 | - | 17.5 | 1,211,794 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.12 per share. | 26 Nov 2025 | 69,404 | 0 | - | 40.1 | 2,784,488 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 69,404 | 49,266 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 5,521 | 43,745 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Nov 2025 | 5,521 | 5,521 | - | 17.5 | 96,397 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.09 per share. | 26 Nov 2025 | 5,521 | 0 | - | 40.1 | 221,337 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 24 Nov 2025 | 18,020 | 0 | - | 40.0 | 721,341 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 18,020 | 118,670 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 24 Nov 2025 | 18,020 | 18,020 | - | 17.5 | 314,629 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 24 Nov 2025 | 100 | 100 | - | 17.5 | 1,746 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 100 | 136,690 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 24 Nov 2025 | 100 | 0 | - | 40 | 4,000 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 61,849 | 136,790 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 35.23 per share. | 30 Sep 2025 | 61,849 | 0 | - | 35.2 | 2,178,940 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 30 Sep 2025 | 61,849 | 61,849 | - | 17.5 | 1,079,884 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 12 Sep 2025 | 22,532 | 22,532 | - | 17.5 | 393,409 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2025 | 22,532 | 198,839 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 35.63 per share. | 12 Sep 2025 | 21,232 | 1,300 | - | 35.6 | 756,496 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 36.31 per share. | 12 Sep 2025 | 1,300 | 0 | - | 36.3 | 47,203 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 12 Sep 2025 | 200 | 0 | - | 35.0 | 7,002 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 12 Sep 2025 | 200 | 200 | - | 17.5 | 3,492 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2025 | 200 | 198,639 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 10 Sep 2025 | 31,338 | 31,338 | - | 17.5 | 547,161 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 31,338 | 240,452 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 36.12 per share. | 10 Sep 2025 | 30,138 | 1,200 | - | 36.1 | 1,088,585 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 19,081 | 221,371 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 10 Sep 2025 | 19,081 | 0 | - | 36.3 | 692,259 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 10 Sep 2025 | 19,081 | 19,081 | - | 17.5 | 333,154 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 36.77 per share. | 10 Sep 2025 | 1,200 | 0 | - | 36.8 | 44,124 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 129,518 | 129,518 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 47,297 | 47,297 | - | - | Restricted Share Units | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 28 Feb 2024 | 36,509 | 36,509 | - | 17.5 | 637,447 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 36,509 | 271,790 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 67.61 per share. | 28 Feb 2024 | 16,900 | 19,609 | - | 67.6 | 1,142,609 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 69.73 per share. | 28 Feb 2024 | 10,937 | 1,200 | - | 69.7 | 762,637 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 68.84 per share. | 28 Feb 2024 | 7,472 | 12,137 | - | 68.8 | 514,372 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.45 per share. | 28 Feb 2024 | 1,200 | 0 | - | 70.5 | 84,540 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Feb 2024 | 54,938 | 54,938 | - | 17.5 | 959,217 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 54,938 | 308,299 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Feb 2024 | 28,553 | 28,553 | - | 17.5 | 498,535 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | Berman David | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 28,553 | 363,237 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings PLC (ADR) | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.60 per share. | 26 Feb 2024 | 26,516 | 2,037 | - | 70.6 | 1,872,030 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.32 per share. | 26 Feb 2024 | 25,944 | 3,394 | - | 71.3 | 1,850,326 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.42 per share. | 26 Feb 2024 | 21,152 | 29,338 | - | 70.4 | 1,489,524 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 69.45 per share. | 26 Feb 2024 | 4,448 | 50,490 | - | 69.5 | 308,914 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.97 per share. | 26 Feb 2024 | 3,394 | 0 | - | 72.0 | 244,266 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.31 per share. | 26 Feb 2024 | 2,037 | 0 | - | 71.3 | 145,258 | Ordinary Shares |
| Immunocore Holdings PLC (ADR) | Berman David | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 111,244 | 111,244 | - | - | Employee Share Option (Right to Buy) |